Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Certreat Scours Oblets 62500 Unit Tablet is a Health Canada–registered veterinary drug (DIN 00084670) held by Cyanamid Canada Inc., containing Vitamin A. Health Canada lists its status as Cancelled Post Market (status date 22 Aug 2000). Nexara Health has matched 72 registrations of Vitamin A across 5 other regulated markets, 8 of them in the same strength and dosage form. A Canadian shortage record is open for this DIN.

Health Canada registration

DIN00084670
Brand nameCertreat Scours Oblets
Active ingredientVitamin A
Strength62500 Unit
Dosage formTablet
RouteOral
CompanyCyanamid Canada Inc.
StatusCancelled Post Market — 22 Aug 2000
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Canadian shortage status

Health Canada shortage reporting lists this DIN as active (updated 2026-09-11). Reported reason: 250MG. Estimated resolution: . See the shortage pulse page for the timeline and marketed alternatives. Source: Drug Shortages Canada.

Vitamin A registered in other markets

72 registrations of the same molecule in 5 national registries outside Canada (first 18 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
TaiwanA.e.s.c. Tablets "Kingdom"景德製藥股份有限公司土城工廠糖衣錠已註銷TFDA
TaiwanA.e.s.c.tablets "Kingdom"景德製藥股份有限公司土城工廠糖衣錠已註銷TFDA
TaiwanAetomin Tablets "S.c."中生生技製藥股份有限公司淡水廠錠劑RegisteredTFDA
TaiwanApluse Chewable S.c. Tablets "Union"佑寧生物科技股份有限公司糖衣錠已註銷TFDA
TaiwanArcavit A Coated TabletsMerck Gesellschaft Mbh糖衣錠已註銷TFDA
TaiwanAvitol-DrageesLannacher Heimittel g. M. B. H.糖衣錠已註銷TFDA
TaiwanDe-A-Vit S.c. TabletsE Denk O.h.g. Pharmazeutika糖衣錠已註銷TFDA
TaiwanDe-A-Vit TabletsE Denk O.h.g. Pharmazeutika糖衣錠已註銷TFDA
Saudi ArabiaHylo VitA—250InactiveSFDA
United Arab EmiratesHYLO NIGHT Eye OintmentURSAPHARM ARZNEIMITTEL GMBH, Germany, Sarrbrucken250 IU/1gOintmentActiveEDE
United Arab EmiratesRetoMed Eye OintmentFARMIGEA SpA.., Italy, Pisa25,000 I.U/100 gOintmentActiveEDE
United KingdomVitamin A 100,000units/2ml solution for injection ampoules—0001NHS dm+d VMP
United KingdomVitamin A 100,000units/2ml solution for injection vials—0001NHS dm+d VMP
United StatesAquasol ACasper Pharma LLCInjection, SolutionFDA NDC
United StatesSkineezCause For Change LLCClothFDA NDC
United StatesVitamin A and DMidwood Brands, LLCOintmentlistedFDA NDC
United StatesVITAMIN A and DAllied Trade Link LLCOintmentlistedFDA NDC
United StatesVitamin A PalmitateDSM Nutritional Products, LLCOilFDA NDC

See every manufacturer of Vitamin A worldwide →

Regulator price references for Vitamin A

Published list or reimbursement prices for Vitamin A presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

CountryProductStrengthPackPriceTypeSourceAs of
Saudi ArabiaHylo VitA34.25 SARpublicSFDA2026-09-01
United Arab EmiratesHYLO NIGHT Eye Ointment250iu/1000mg5g Aluminum Tube.21.50 AEDpublicEDE2026-08-31
United Arab EmiratesRetoMed Eye Ointment100000mg5g Aluminium Tube125.00 AEDpublicEDE2026-08-31

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Certreat Scours Oblets (DIN 00084670) marketed in Canada?

No. Health Canada lists DIN 00084670 as Cancelled Post Market as of 22 Aug 2000.

Who holds the Canadian licence for this product?

Cyanamid Canada Inc. is the company of record in the Health Canada Drug Product Database.

Is Vitamin A registered outside Canada?

Yes — Nexara Health has matched 72 registrations in 5 other markets, including 8 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00084670, status date 2000-08-22; national medicine registries: EDE, FDA NDC, NHS dm+d VMP, SFDA, TFDA; price sources: EDE, SFDA; Drug Shortages Canada (drugshortagescanada.ca). Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00084670, status date 2000-08-22; national medicine registries: EDE, FDA NDC, NHS dm+d VMP, SFDA, TFDA; price sources: EDE, SFDA; Drug Shortages Canada (drugshortagescanada.ca).

Health Canada Drug Product Database (DPD), DIN 00084670, status date 2000-08-22; national medicine registries: EDE, FDA NDC, NHS dm+d VMP, SFDA, TFDA; price sources: EDE, SFDA; Drug Shortages Canada (drugshortagescanada.ca). Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.